MIST

Milestone Pharmaceuticals Inc.

Healthcare · Biotechnology

$147.52 sample

-1.75 (-1.17%) 1D

Market cap

$865.9B

Price as of

2026-10-04

Latest filing

8-K · 2026-08-31

Alerts

8

Price$147.52 +13.96% 3M daily closessample

150.06129.31

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 24INSInsider buy: Chief Executive Officer
Sep 16INSInsider sell: 10% owner
Sep 11INSInsider sell: General Counsel
Sep 08INSInsider sell: EVP, Operations
Aug 31SECForm 144 filed
Aug 24INSInsider buy: Chief Executive Officer
Aug 18INSInsider sell: 10% owner
Aug 12INSInsider sell: 10% owner

Sign up to see the real MIST record →

Company facts

SEC EDGAR registration

Name: Milestone Pharmaceuticals Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -37sample, -100 to +100
Reporting currency: USD

Who is positioning in MIST

sample

Insiders: 11 insider transactions over 90 days, net selling, $62.7M
Congress: 1 members traded over 90 days
Institutions · 13F: 28 funds hold $10.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$49.0B +17.6% y/y

Q4 2024Q3 2026

Inventory$29.3B +17.1% y/y

Q4 2024Q3 2026

Accounts receivable$21.0B +10.6% y/y

Q4 2024Q3 2026

Total debt$56.3B +7.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $372.4B +3.4% 3M
Sample peer B: $625.3B +15.5% 3M
Sample peer C: $647.5B +6.0% 3M
Sample peer D: $561.8B -9.9% 3M
Sample peer E: $820.0B -5.6% 3M